Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 5/12/15  and contains information from public web pages and contributions from the ZoomInfo community.

Mr. Martin S. Kleckner III

Wrong Martin S. Kleckner III?

Healthcare Executive

RefluxMD Inc
10804 Willow Ct. B
San Diego , California 92127
United States

Company Description: RefluxMD delivers users authoritative, detailed, physician-approved information and even helps connect them with doctors in their area who specialize in reflux...   more
Background

Employment History

  • Senior Vice President
    RefluxMD Inc
  • Institute Co-Founder, Business Adviser and Principal
    La Costa Group LLC
  • Managing Principal
    La Costa Group LLC
  • Founder and Chief Executive Officer
    U P Laboratories
  • Managing Principal
    Costa Group, LA
  • Division President
    LuminOre Healthcare
  • Chief Operations Officer
    NICHOLAS CONOR INSTITUTE
  • Chief Operations Officer
    The Nicholas Conor Institute for Pediatric Cancer Research , Inc.
  • Chief Operations and Business Development Officer
    The Nicholas Conor Institute for Pediatric Cancer Research , Inc.
  • Chief Executive Officer; Business Development - Commercialization
    U P Technologies
  • Senior Business Consultant
    Orange County SBDC
  • Director of Development
    Science and Engineering Associates
  • Vice President of Development
    Science and Engineering Associates

Board Memberships and Affiliations

Education

  • MBA
    University of California , Los Angeles
  • PhD , Public Policy
    University of California , Riverside
  • Bachelor of Arts ( BA , public policy and economics
    Whittier College
21 Total References
Web References
Our Team | RefluxMD - Your guide to lifetime reflux relief
www.refluxmd.com, 12 May 2015 [cached]
Martin Kleckner
Martin Kleckner is a seasoned healthcare executive and entrepreneur with over 26 years of experience building technology firms and advising both start-up entities and large public companies. He is recognized for his expertise in business development, commercialization, capitalization and mentoring of healthcare start-up ventures. He has substantial experience guiding both emerging and Fortune 100 companies with new technology commercialization throughout Europe, Asia and the Americas. Mr. Kleckner earned his undergraduate degree from Whittier College, his master's in business administration from the University of California, Los Angeles, and a PhD in Public Policy from the University of California, Riverside.
CureWize
www.curewize.com, 22 Feb 2015 [cached]
Dr. Martin S. Kleckner III, Senior VP for RefluxMD and Division President for LuminOre Healthcare Martin concentrates on business development, commercialization, capitalization and mentoring of life science start-up ventures including 501(3)c not-for-profit initiatives. His background comprises 26 years guiding emerging and Fortune 100 companies with new technology commercialization throughout Europe, Asia & the Americas. Martin served as the Chief Operations and Business Development Officer for The Nicholas Conor Institute for Pediatric Cancer Research, Inc., specializing in the translation of new molecular biology (genomics and proteomics) diagnostics and treatments. He further provides commercialization advisory support to the National Institutes of Health, Drexel Foundation, Wallace H. Coulter Foundation, and Foresight Science & Technology with regard to “Go/No-Go� grant funding decisions and post-funding commercialization guidance.
Martin Kleckner - TriTech Consultant
www.tritechsbdc.org, 7 July 2013 [cached]
Martin Kleckner Picture v2
...
Martin Kleckner
Senior Business Consultant
...
Mr. Kleckner's background comprises 26 years on senior level operations, general management, marketing and business development in the life sciences, oil & gas, cable television, counter-intelligence and aerospace. His current work encompasses guiding emerging and established companies with corporate planning and strategy, commercialization and business development, marketing, and public policy throughout Europe, Asia & the Americas.
He is a co-founder of RefluxMD.com, a Health 2.0 Internet company specializing in gastroesophageal reflux disease. He further provides commercialization advisory support to the National Institutes of Health, Drexel Foundation, and Coulter Foundation with regard to awarded grants plus "Go/No-Go" grant funding decisions. He was previously Chief Operations Officer for The Nicholas Conor Institute for Pediatric Cancer Research, Inc., a 501 (c) 3 not-for-profit enterprise specializing in the translation and advancement of new molecular biology (genomics and proteomics) diagnostics and treatments via foundation and corporate life science partnerships.
Previously he was Chief Executive Officer for U P Laboratories in San Diego for the development of proprietary synthetic peptides (excitation secretion uncoupling peptides) as an alternative to botulinum neurotoxin (BoTox®) for topical anti-aging/wrinkle inhibition and hyperhidrosis. Earlier he was Senior Vice President for Business Development at InSilicoMed, a start-up company providing bioengineering simulation tools for cardiology and ophthalmic therapy applications; Senior Vice President of Business Development and angel investor for RegeneMed, a company creating three dimensional (3D) engineered liver tissue for drug discovery and bio-artificial liver support; co-founder and Chief Business Officer for Salvino-Flex LLC wherein he managed the research and development of a chest tube insertion device, ultimately selling the company. He was also Director of Development for Science and Engineering Associates for the commercialization of a diagnostic technology applicable to cervical, ovarian and oral/pharyngeal cancers.
He has further served as healthcare economist for Roche, Respironics, Toshiba Medical, and Terumo Interventional while also teaching courses for General Electric at its Crotonville, New York campus. He was the co-founder/CEO of a counter-intelligence device which was showcased worldwide on BBC, NBC, CBS and Fox (receiving an 11-minute lead story) and then was used to help solve a crime in a May 2004 episode of 'CSI Miami'. Previously he was Director of Venture Development/Contracts Executive with American Healthcare Systems serving in the starting group growing the company to $45 million in annual revenue eventually selling to Premier, Inc. He was General Manager for Times Mirror with direct responsibility for its leading cable television performer (a $19 million division), and launched a nationwide initiative for cable system reorganization, mergers, swaps, and divestitures eventually leading to sale of the remaining company to Cox Communications. Finally he was Corporate Planning Analyst for Berry Industries and California Shipbuilding specializing in mergers and acquisitions plus served as legislative advocate in the California state Senate and Assembly and Washington DC.
Mr. Kleckner's education consists of an MBA from the University of California, Los Angeles (UCLA) Anderson School; a PhD in Public Policy from the University of California, Riverside; a certificate in public health from the University of California, San Diego (UCSD); and a Bachelor of Arts (BA) with concentrations in public policy and economics from Whittier College.
FLEX PARTNERS, INC. - Bio's - Martin Kleckner, III - Director, Business Development
www.flex-partners.com, 21 Oct 2005 [cached]
Martin Kleckner
...
Martin Kleckner
solutions ... ideasBio's - Martin Kleckner, III - Director, Business Development
Mr. Kleckner has twenty four (24) years experience in strategic planning, business development, operations and financial management.His background comprises heavy experience in development and management of internal operations, corporate strategies, and conditions impacting company performances.
Mr. Kleckner is the founder of La Costa Group, LLC www.lacostagroup.com, a multi-partner consultancy based in Carlsbad, California where he has assisted over 65 companies, both emerging businesses and Fortune 100 corporations with new technology commercialization, capitalization, general management, strategic planning and business development.He has taught programs in sales & marketing, finance, and business economics throughout Europe, Asia and the Americas for several companies including General Electric, Honeywell, Allied Signal, Roche Diagnostics, Toshiba America Medical, AGFA, Fuji Medical, and Hewlett Packard.Before founding La Costa Group, he was Director of Venture Development & Contract Executive at American Healthcare Systems where he was responsible for medical device market growth alliances.At Times Mirror Cable Systems, he served senior positions in finance and marketing and was General Manager for a $17 million division where he had full profit and loss accountability with 155 employees, leading it as the highest financially performing division in 1985 & 1986.He is a former legislative advocate representing businesses in the California state legislature & Washington D.C.
Mr. Kleckner earned his MBA from the University of California, Los Angeles (UCLA), an MA in Public Policy from the University of California, Riverside, and holds a BA from Whittier College.He has completed all Ph.D. requirements except dissertation from the University of California and received a certificate in healthcare executive management from the University of California, San Diego.He is a frequent lecturer at national conferences and regularly contributes articles to medical industry journals.
Martin Kleckner, institute ...
www.sdbj.com, 8 Nov 2010 [cached]
Martin Kleckner, institute co-founder, business adviser and principal of La Costa Group LLC, a Carlsbad firm that consults with clients on developing medical technology ventures, described the approach as one that encompasses the deployment of a blend of charitable funds and grants with venture and corporate development capital that industry partners already have. Kleckner, who has 15 years of experience working for medical device and life sciences companies, said TNCI's partners benefit by receiving licensing fees from the commercialization of intellectual property.
The institute is now engaged in a 30-month campaign using this model to raise the $15 million during a three-phase development process.
Kleckner said the organization hopes to get the ball rolling by a major donor campaign, writing successful grants and seeking the assistance of foundations.
Other People with the name "Kleckner":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.
zirhbt201304